PRODUCT DESCRIPTION:

Desogestrel & Ethinylestradiol Tablets are modern combined oral contraceptives (COCs) that offer highly effective pregnancy prevention along with added benefits of cycle regulation, reduced menstrual pain, and clearer skin.

Desogestrel, a third-generation progestin, is known for its favorable lipid profile and low androgenic activity. Ethinylestradiol, a synthetic estrogen, complements its action by stabilizing the endometrium and supporting menstrual regularity. 

Together, they provide ovulation suppression, alteration of cervical mucus, and endometrial thinning, making conception highly unlikely when taken as prescribed.

This combination is preferred by gynecologists for its reliability, tolerability, and metabolic safety, especially in women seeking both contraceptive and therapeutic hormonal benefits.

Formulation & Presentation:

• Dosage Form: Tablets
• Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
• Available Strengths: Desogestrel + Ethinylestradiol Tablets
  • Desogestrel 0.15 MG + Ethinylestradiol 0.03 MG
  • Desogestrel 0.30 MG + Ethinylestradiol 0.02 MG
  • Desogestrel 0.35 MG + Ethinylestradiol 0.02 MG
• Route of Administration: Oral (As per physician’s discretion or therapeutic indication)

Therapeutic Indications:

• Routine oral contraception
• Regulation of irregular menstrual cycles
• Treatment of mild to moderate acne (in hormone-responsive women)
• Management of dysmenorrhea (painful periods)
• Hormonal balance in polycystic ovarian syndrome (PCOS)

Side Effects:

• COMMON:  Nausea, Headache, Breast tenderness, Bloating, Mood changes, Breakthrough bleeding or spotting
• SERIOUS (RARE): Thromboembolic disorders (deep vein thrombosis, pulmonary embolism), Stroke or myocardial infarction (especially in smokers above 35), Liver dysfunction or jaundice, Hypertension
• PRECAUTIONS: Contraindicated in women with a history of thromboembolic events, breast or endometrial cancer, or severe hepatic impairment
  • Not recommended during pregnancy or lactation
  • Should be used cautiously in women with hypertension, diabetes, or migraines
  • Does not offer protection against HIV or other sexually transmitted infections (STIs)
  • Routine medical supervision is advised during long-term use